Mankind Pharma Limited Share Price

Equities

MANKIND

INE634S01028

Pharmaceuticals

Market Closed - NSE India S.E. 05:13:54 14/06/2024 pm IST 5-day change 1st Jan Change
2,241 INR +0.02% Intraday chart for Mankind Pharma Limited +3.91% +13.02%
Sales 2024 103B 1.24B Sales 2025 * 116B 1.39B Capitalization 898B 10.74B
Net income 2024 19.13B 229M Net income 2025 * 22.07B 264M EV / Sales 2024 8.92 x
Net cash position 2024 * 25.25B 302M Net cash position 2025 * 40.68B 487M EV / Sales 2025 * 7.37 x
P/E ratio 2024
48.3 x
P/E ratio 2025 *
40.7 x
Employees 18,468
Yield 2024 *
0.28%
Yield 2025 *
0.4%
Free-Float 19.92%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.06%
1 week+5.23%
Current month+4.63%
1 month-0.44%
3 months+5.50%
6 months+18.54%
Current year+12.93%
More quotes
1 week
2 136.10
Extreme 2136.1
2 276.00
1 month
1 931.35
Extreme 1931.35
2 299.00
Current year
1 931.35
Extreme 1931.35
2 490.00
1 year
1 585.00
Extreme 1585
2 490.00
3 years
1 242.00
Extreme 1242
2 490.00
5 years
1 242.00
Extreme 1242
2 490.00
10 years
1 242.00
Extreme 1242
2 490.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 48 21/07/21
Director of Finance/CFO 55 17/16/17
Compliance Officer - 23/16/23
Members of the board TitleAgeSince
Director/Board Member 60 01/22/01
Director/Board Member 71 01/22/01
Director/Board Member 61 19/15/19
More insiders
Date Price Change Volume
14/24/14 2,241 +0.02% 373 904
13/24/13 2,240 +0.68% 1,038,935
12/24/12 2,225 +2.68% 385,990
11/24/11 2,167 -0.30% 300,668
10/24/10 2,174 +2.16% 544,770

Delayed Quote NSE India S.E., June 14, 2024 at 02:39 pm IST

More quotes
Mankind Pharma Limited is an India-based pharmaceutical company. The Company is engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. The Company offers exceptional healthcare solutions for a wide range of healthcare needs with a diverse portfolio that includes anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/ central nervous system (CNS), vitamins, minerals and nutrients and respiratory therapies. Its portfolio of brands includes Nurokind, Telmikind, Manforce (Rx), Gudcef, Moxikind, Amlokind, Glimestar, Asthakind, Codistar, Candiforce, Mahacef, Dydroboon, Cefakind, Zenflox, Monticope, Dynaglipt, and others. The Company's subsidiaries include Lifestar Pharma Private Limited, Magnet Labs Private Limited, Broadway Hospitality Services Private Limited, Jaspack Industries Private Limited, and others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
2,240 INR
Average target price
2,292 INR
Spread / Average Target
+2.33%
Consensus
  1. Stock Market
  2. Equities
  3. MANKIND Stock